Article Details
Retrieved on: 2019-03-29 10:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Sofinnova Ventures</b> Inc bought a new position in Y-mAbs Therapeutics in the 3rd quarter valued at about $55,890,000. Scopia Capital Management ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here